{"id":56144,"name":"ADAMIS PHARMACEUTICALS CORPORATION","slug":"adamis-pharmaceuticals-corporation","state":"CA","country":"United States of America","description":"Pharmaceuticals manufacturing","totalSpending":80000,"filings":4,"yearlySpending":[{"year":2023,"income":80000}],"issues":["HCR"],"firms":["COVINGTON & BURLING LLP"],"lobbyists":["GARY HEIMBERG","GABRIEL NEVILLE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Legislation and rulemakings relating to opioid abuse and Naloxone access.","Legislation and rulemakings relating to opioid abuse and Naloxone access; H.R. 4007, the HEAL Act; H.R. 4531, the Support for Patients and Communities Reauthorization Act."],"years":[2023]}